Response prediction of transfusions with Ketamine as add-on in depressive non-responders

Response prediction of transfusions with Ketamine as add-on in depressive non-responders - EVKETD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00025568

Enrollment

Registered

2021-06-18

Start date

2021-07-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F33 F32

Interventions

Group 1: Ketamine transfusion as add-on to antidepressant medication

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Severe depressive episode that did not respond on treatment with at least one adequately dossed antidepressant for at least four weeks.

Exclusion criteria

Exclusion criteria: Underage, not capable to understand the study rational or to give consent voluntarily.

Design outcomes

Primary

Measure	Time frame
Positive response to transfusions within eight days after first transfusion.	—

Secondary

Measure	Time frame
Success of treatment at the end of treatment.	—

Countries

Germany

Contacts

Public ContactBartosz Zurowski

ZIP Lübeck

bartosz.zurowski@uksh.de+4945150098831

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026